SCHEMBL2237340

SCHEMBL2237340

CC(N)=C(C(=O)O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
ALOX15 P16050 1/20 0.47
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
LDHA P00338 1/20 0.44
LDHB P07195 1/20 0.44
ACHE P22303 1/20 0.40
FFAR3 O14843 1/20 0.40
LCK P06239 1/20 0.40
FYN P06241 1/20 0.40
TDP1 Q9NUW8 2/20 0.37
ALDH1A1 P00352 1/20 0.33
OR51E2 Q9H255 1/20 0.33
CRBN Q96SW2 1/20 0.33
TSHR P16473 1/20 0.31
THPO P40225 1/20 0.31
TAS2R38 P59533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11229978 0.87 LMNA (0.41) LMNAALOX15BLMPMP22LDHA
SCHEMBL11229973 0.87 LMNA (0.41) LMNAALOX15BLMPMP22LDHA
SCHEMBL18424789 0.87 LMNA (0.41) LMNAALOX15BLMPMP22LDHA
SCHEMBL15148211 0.82 LMNA (0.37) LMNAALOX15BLMPMP22LDHA
SCHEMBL3975179 0.81
SCHEMBL14657296 0.76 TSHR (0.35) LMNAALOX15BLMPMP22LDHA
SCHEMBL18425552 0.74 LMNA (0.50) LMNAALOX15BLMPMP22ACHE
SCHEMBL9033319 0.73 LDHA (0.47) LMNAALOX15BLMPMP22LDHA
Oxalic Acid SCHEMBL11065208 0.72 LMNA (0.73) LMNAALOX15BLMPMP22LDHA
Oxalic Acid SCHEMBL28860992 0.72 LMNA (0.73) LMNAALOX15BLMPMP22LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536690-B1 MULTIFUNCTIONAL RADICAL QUENCHERS AND THEIR USE UNIV ARIZONA (US) 2018-08-08 EP disclosed
CN-108047201-A Uracil derivative as AXL and c-MET kinase inhibitors 亚尼塔公司 2018-05-18 CN disclosed
CN-106029661-B Pyrazolo [1,5-A ] pyridine derivatives and methods of use thereof 亚尼塔公司 2017-11-03 CN disclosed
CN-103958497-B uracil derivatives as AXL and c-MET kinase inhibitors 亚尼塔公司 2017-09-01 CN disclosed
CN-106029661-A Pyrazolo [1,5-A ] pyridine derivatives and methods of use thereof 亚尼塔公司 2016-10-12 CN disclosed
US-8952025-B2 Multifunctional radical quenchers and their uses ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2015-02-10 US disclosed
US-20130267546-A1 Multifunctional Radical Quenchers and Their Uses Arizona Board of Regents, a body corporate of the State of Arizona acting for and on behalf of Ari (US) 2013-10-10 US disclosed
EP-2536690-A1 MULTIFUNCTIONAL RADICAL QUENCHERS AND THEIR USE Arizona Board Of Regents (US) 2012-12-26 EP disclosed
WO-2011103536-A1 MULTIFUNCTIONAL RADICAL QUENCHERS AND THEIR USE ARIZONA BOARD OF REGENTS (US) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130267546-A1 Multifunctional Radical Quenchers and Their Uses SQOR, GSR, GPX4 LMNA 1653/4885ALOX15 220/4885BLM 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.